Investigating the role of a specific protein in ALS

Protein Arginine Deiminase 2 (PAD2) and Protein Citrullination in ALS

NIH-funded research Univ of Massachusetts Med Sch Worcester · NIH-11079644

This study is looking at how a protein called PAD2 and a process called citrullination might affect the nerve damage seen in ALS, with the goal of finding new ways to help people with this condition.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniv of Massachusetts Med Sch Worcester NIH-funded
Lab location1 site (Worcester, United States)
Project IDNIH-11079644 on NIH RePORTER

What this research studies

This research focuses on understanding the role of Protein Arginine Deiminase 2 (PAD2) and the process of protein citrullination in the progression of Amyotrophic Lateral Sclerosis (ALS). The researchers aim to uncover how these mechanisms contribute to motor neuron degeneration, which is a hallmark of ALS. By studying the effects of PAD2 and citrullination on protein function and interactions within the central nervous system, the team hopes to identify new therapeutic targets. This collaborative effort combines expertise from two labs to explore previously uncharted areas in ALS research.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals diagnosed with Amyotrophic Lateral Sclerosis (ALS).

Not a fit: Patients with other neurodegenerative diseases that do not involve ALS may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies that may slow down or halt the progression of ALS.

How similar studies have performed: While there has been significant research on PADs in other neurodegenerative diseases, this specific investigation into PAD2's role in ALS is novel and has not been extensively studied.

Where this research is happening

Worcester, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's DiseaseAmyotrophic Lateral Sclerosis Motor Neuron Disease
Last reviewed 2026-06-10 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.